A first-in-class molecule can prevent breast cancer growth when traditional therapies stop working, new research indicates.
First-in-class drug holds promise for therapy-resistant breast cancer
Science Daily - 8 Aug 2017 22:54
A first-in-class molecule can prevent breast cancer growth when traditional therapies stop working, new research indicates.
Share this Article
Recommended